EDWARD GRAVISS to Heart-Assist Devices
This is a "connection" page, showing publications EDWARD GRAVISS has written about Heart-Assist Devices.
Connection Strength
0.709
-
Impact of statins on incidence of gastrointestinal bleeding events among patients with continuous-flow left ventricular assist devices. Int J Artif Organs. 2024 Nov; 47(11):826-835.
Score: 0.128
-
Tissue plasminogen activator in left ventricular assist device-related intravascular hemolysis after failed augmented anticoagulation. Int J Artif Organs. 2022 Nov; 45(11):911-918.
Score: 0.110
-
A multi-institutional retrospective analysis on impact of RV acute mechanical support timing after LVAD implantation on 1-year mortality and predictors of RV acute mechanical support weaning. J Heart Lung Transplant. 2022 02; 41(2):244-254.
Score: 0.104
-
Endothelial Dysfunction-related Neurological Bleeds with Continuous Flow-Left Ventricular Assist Devices Measured by Digital Thermal Monitor. ASAIO J. 2021 05 01; 67(5):561-566.
Score: 0.101
-
Role of thromboelastography in predicting and defining pump thrombosis in left ventricular assist device patients. Thromb Res. 2020 08; 192:29-35.
Score: 0.093
-
Waitlist and post-transplant outcomes in patients listed with intra-aortic balloon pump for heart transplant: United Network for Organ Sharing registry. Int J Artif Organs. 2020 Sep; 43(9):606-613.
Score: 0.093
-
Risk Stratification of Patients With Current Generation Continuous-Flow Left Ventricular Assist Devices Being Bridged to Heart Transplantation. ASAIO J. 2018 Mar/Apr; 64(2):196-202.
Score: 0.081